Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
astrocytoma and breast cancer
levels of immune checkpoints are modulated by treatment with CPI-444
Sitafloxacin (DU6859a) is a potent
Research has shown that pimobendan increases survival time and improves quality of life in canine patients with congestive heart failure secondary to mitral valve disease when compared with benazepril
1517/17425247
Tipiracil Hydrochloride Catalog No.:M9551-10 astrocytoma and breast cancerTipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS 102, which is an anticancer drug candidate currently in clinical trials. TAS 102 consists of the cytotoxin Trifluridine and the thymidine phosphorylase inhibitor (TPI) tipiracil. Trifluridine is incorporated into DNA during DNA synthesis and inhibits tumor cell growth. Tipiracil protects trifluridine from being broken down